EAM
CBAY

Eagle Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Eagle Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,867
Closed -$21K – 691
2020
Q4 		$21K Buy
+3,867
New +$29.3K ﹤0.01% 556
2019
Q4 		– Sell
-2,334,861
Closed -$12M – 662
2019
Q3 		$12M Sell
2,334,861
-438,790
-16% -$2.66M 0.06% 281
2019
Q2 		$19.9M Sell
2,773,651
-237,972
-8% -$2.69M 0.1% 232
2019
Q1 		$40M Buy
3,011,623
+158,650
+6% +$1.69M 0.21% 181
2018
Q4 		$22.5M Buy
2,852,973
+8,207
+0.3% +$78.1K 0.14% 212
2018
Q3 		$31.5M Buy
2,844,766
+781,700
+38% +$9.71M 0.15% 210
2018
Q2 		$27.7M Buy
+2,063,066
New +$25.8M 0.15% 211

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return